Clinical Trial Update: 6-Month Extension Trial of Asenapine With Olanzapine in Negative Symptoms Patients Who Completed the First 6- Month Trial (A7501014)(COMPLETED)(P05772) [Phase 3]

View source ↗

Summary

A completed Phase 3 trial extension evaluating 6 months of asenapine with olanzapine in schizophrenia patients with negative symptoms; results posted in 2010.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• Asenapine (asenapine)
• olanzapine (olanzapine)

Snippet

Sponsor: Organon and Co | Conditions: Schizophrenia | Phase 3 | Status: COMPLETED | Results posted: 2010-07-05